z-logo
open-access-imgOpen Access
Pharmacogenetic testing for CYP2C19 gene polymorphism for optimization of using antiplatelet therapy in patients with ischemic heart disease
Author(s) -
О. О. Карпенко
Publication year - 2016
Publication title -
sciencerise medical science
Language(s) - English
Resource type - Journals
eISSN - 2519-4798
pISSN - 2519-478X
DOI - 10.15587/2519-4798.2016.76377
Subject(s) - cyp2c19 , clopidogrel , genotype , medicine , allele , gene polymorphism , gastroenterology , polymorphism (computer science) , aspirin , myocardial infarction , coronary artery disease , pharmacogenetics , platelet , pharmacology , gene , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom